SitesBLAST
Comparing Ga0059261_3811 FitnessBrowser__Korea:Ga0059261_3811 to proteins with known functional sites using BLASTp with E ≤ 0.001.
Or try Sites on a Tree, PaperBLAST, Conserved Domains, or compare to all protein structures
Found 20 (the maximum) hits to proteins with known functional sites (download)
A0R066 Branched-chain-amino-acid aminotransferase; BCAT; EC 2.6.1.42 from Mycolicibacterium smegmatis (strain ATCC 700084 / mc(2)155) (Mycobacterium smegmatis) (see 2 papers)
56% identity, 98% coverage: 6:361/362 of query aligns to 8:367/368 of A0R066
- R101 (= R99) binding pyridoxal 5'-phosphate
- Y209 (= Y206) binding pyridoxal 5'-phosphate
- K299 (≠ A293) modified: Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup)
- T314 (= T308) binding pyridoxal 5'-phosphate
3dtgA Structural analysis of mycobacterial branched chain aminotransferase- implications for inhibitor design
56% identity, 98% coverage: 6:361/362 of query aligns to 3:362/363 of 3dtgA
- active site: K199 (= K201)
- binding O-benzylhydroxylamine: F72 (= F75), Y171 (= Y173), Y204 (= Y206)
- binding pyridoxal-5'-phosphate: R96 (= R99), R189 (= R191), K199 (= K201), Y204 (= Y206), E235 (= E237), G238 (= G240), L263 (= L262), I266 (= I265), T267 (= T266), T309 (= T308)
3dtfA Structural analysis of mycobacterial branched chain aminotransferase- implications for inhibitor design (see paper)
56% identity, 98% coverage: 6:361/362 of query aligns to 3:362/363 of 3dtfA
3ht5A Crystal structure of ilve a branched chain amino acid transaminase from mycobacterium tuberculosis (see paper)
57% identity, 91% coverage: 34:362/362 of query aligns to 3:335/335 of 3ht5A
- active site: K171 (= K201)
- binding 4'-deoxy-4'-aminopyridoxal-5'-phosphate: R68 (= R99), K171 (= K201), Y176 (= Y206), E207 (= E237), G210 (= G240), M211 (= M241), N212 (= N242), L235 (= L262), G237 (= G264), I238 (= I265), T239 (= T266), T281 (= T308)
5u3fA Structure of mycobacterium tuberculosis ilve, a branched-chain amino acid transaminase, in complex with d-cycloserine derivative (see paper)
55% identity, 91% coverage: 34:362/362 of query aligns to 2:326/326 of 5u3fA
- active site: K162 (= K201)
- binding (5-hydroxy-6-methyl-4-{[(3-oxo-2,3-dihydro-1,2-oxazol-4-yl)amino]methyl}pyridin-3-yl)methyl dihydrogen phosphate: G45 (= G77), R67 (= R99), Y110 (= Y141), K162 (= K201), Y167 (= Y206), E198 (= E237), G201 (= G240), M202 (= M241), N203 (= N242), L226 (= L262), G228 (= G264), I229 (= I265), T230 (= T266), T272 (= T308)
7nyaA Crystal structure of human cytosolic branched-chain aminotransferase (bcat1) in complex with plp and small molecule inhibitor bay-069 (compound 36) (see paper)
41% identity, 90% coverage: 25:350/362 of query aligns to 23:354/364 of 7nyaA
- binding pyridoxal-5'-phosphate: R97 (= R99), R190 (= R191), K200 (= K201), Y205 (= Y206), E235 (= E237), T238 (≠ G240), M239 (= M241), L264 (= L262), G266 (= G264), V267 (≠ I265), T268 (= T266), G310 (= G307), T311 (= T308)
- binding 3-[4-chloranyl-3-(2-methylphenoxy)naphthalen-1-yl]-6-(trifluoromethyl)-5~{H}-pyrimidine-2,4-dione: F27 (= F29), Y68 (= Y70), F73 (= F75), Y139 (= Y141), G152 (= G154), V153 (= V155), Y171 (= Y173), Q212 (= Q213), Q222 (= Q223), T238 (≠ G240), A312 (= A309)
7ny9A Crystal structure of human cytosolic branched-chain aminotransferase (bcat1) in complex with plp and small molecule inhibitor compound 38 (see paper)
41% identity, 90% coverage: 25:350/362 of query aligns to 23:354/364 of 7ny9A
- binding pyridoxal-5'-phosphate: R97 (= R99), R190 (= R191), K200 (= K201), Y205 (= Y206), E235 (= E237), T238 (≠ G240), M239 (= M241), N240 (= N242), L264 (= L262), G266 (= G264), V267 (≠ I265), T268 (= T266), T311 (= T308)
- binding 3-[2,6-bis(oxidanylidene)-4-(trifluoromethyl)-5~{H}-pyrimidin-1-yl]-~{N}-methyl-2-pyridin-2-yl-imidazo[1,2-a]pyridine-7-carboxamide: F27 (= F29), Y139 (= Y141), G152 (= G154), V153 (= V155), Y171 (= Y173), Q212 (= Q213), Q221 (≠ D222), Q222 (= Q223), V223 (= V224), T238 (≠ G240)
7ny2A Crystal structure of human cytosolic branched-chain aminotransferase (bcat1) in complex with plp and small molecule inhibitor compound 35 (see paper)
41% identity, 90% coverage: 25:350/362 of query aligns to 23:354/364 of 7ny2A
- binding pyridoxal-5'-phosphate: R97 (= R99), K200 (= K201), Y205 (= Y206), E235 (= E237), T238 (≠ G240), M239 (= M241), L264 (= L262), G266 (= G264), V267 (≠ I265), T268 (= T266), T311 (= T308)
- binding 4-[2,4-bis(oxidanylidene)-6-(trifluoromethyl)-1H-pyrimidin-3-yl]-2-(2-methylphenoxy)naphthalene-1-carbonitrile: F27 (= F29), Y139 (= Y141), G152 (= G154), V153 (= V155), Y171 (= Y173), Q212 (= Q213), Q222 (= Q223), A312 (= A309)
P54687 Branched-chain-amino-acid aminotransferase, cytosolic; BCAT(c); EC 2.6.1.42 from Homo sapiens (Human) (see 2 papers)
41% identity, 90% coverage: 25:350/362 of query aligns to 45:376/386 of P54687
- K222 (= K201) modified: N6-(pyridoxal phosphate)lysine
- G330 (≠ A305) to S: in dbSNP:rs1057204
7nwmA Crystal structure of human cytosolic branched-chain aminotransferase (bcat1) in complex with plp and inhibitor compound 12 (see paper)
41% identity, 90% coverage: 25:350/362 of query aligns to 24:355/365 of 7nwmA
- binding pyridoxal-5'-phosphate: R98 (= R99), R191 (= R191), K201 (= K201), Y206 (= Y206), E236 (= E237), T239 (≠ G240), M240 (= M241), L265 (= L262), G267 (= G264), V268 (≠ I265), T269 (= T266), G311 (= G307), T312 (= T308)
- binding 4-[2,4-bis(oxidanylidene)-6-(trifluoromethyl)-1H-pyrimidin-3-yl]-5-methoxy-2-(2-methylphenoxy)benzenecarbonitrile: F28 (= F29), Y69 (= Y70), F74 (= F75), Y140 (= Y141), G153 (= G154), V154 (= V155), Y172 (= Y173), Q213 (= Q213), Q223 (= Q223), T239 (≠ G240), A313 (= A309)
7nweA Crystal structure of human cytosolic branched-chain aminotransferase (bcat1) in complex with plp and inhibitor compound 10 (see paper)
41% identity, 90% coverage: 25:350/362 of query aligns to 24:355/365 of 7nweA
- binding pyridoxal-5'-phosphate: R98 (= R99), K201 (= K201), Y206 (= Y206), E236 (= E237), T239 (≠ G240), M240 (= M241), L265 (= L262), G267 (= G264), V268 (≠ I265), T269 (= T266), G311 (= G307), T312 (= T308)
- binding 4-[2,4-bis(oxidanylidene)-6-(trifluoromethyl)-1H-pyrimidin-3-yl]-5-methyl-2-(2-methylphenoxy)benzenecarbonitrile: F28 (= F29), Y69 (= Y70), F74 (= F75), Y140 (= Y141), G153 (= G154), V154 (= V155), Y172 (= Y173), Q213 (= Q213), Q223 (= Q223), T239 (≠ G240), A313 (= A309)
7nwcA Crystal structure of human cytosolic branched-chain aminotransferase (bcat1) in complex with plp and inhibitor compound 2 (see paper)
41% identity, 90% coverage: 25:350/362 of query aligns to 24:355/365 of 7nwcA
- binding pyridoxal-5'-phosphate: R98 (= R99), R191 (= R191), K201 (= K201), Y206 (= Y206), E236 (= E237), T239 (≠ G240), M240 (= M241), N241 (= N242), L265 (= L262), G267 (= G264), V268 (≠ I265), T269 (= T266), G311 (= G307), T312 (= T308)
- binding 3-(5-chloranyl-2,4-dimethoxy-phenyl)-6-(trifluoromethyl)-1H-pyrimidine-2,4-dione: F28 (= F29), Y172 (= Y173), Q223 (= Q223), T239 (≠ G240), A313 (= A309)
7nwbA Crystal structure of human cytosolic branched-chain aminotransferase (bcat1) in complex with plp and inhibitor compound 1 (see paper)
41% identity, 90% coverage: 25:350/362 of query aligns to 24:355/365 of 7nwbA
- binding pyridoxal-5'-phosphate: R98 (= R99), R191 (= R191), K201 (= K201), Y206 (= Y206), E236 (= E237), T239 (≠ G240), M240 (= M241), L265 (= L262), G267 (= G264), V268 (≠ I265), T269 (= T266), G311 (= G307), T312 (= T308)
- binding 4-[2,4-bis(oxidanylidene)-6-(trifluoromethyl)-1H-pyrimidin-3-yl]-5-fluoranyl-2-(2-methylphenoxy)benzenecarbonitrile: F28 (= F29), Y69 (= Y70), F74 (= F75), Y140 (= Y141), G153 (= G154), V154 (= V155), Y172 (= Y173), Q213 (= Q213), Q223 (= Q223), A313 (= A309)
7nwaA Crystal structure of human cytosolic branched-chain aminotransferase (bcat1) in complex with plp and compound a (see paper)
41% identity, 90% coverage: 25:350/362 of query aligns to 24:355/365 of 7nwaA
- binding pyridoxal-5'-phosphate: R98 (= R99), K201 (= K201), Y206 (= Y206), E236 (= E237), T239 (≠ G240), N241 (= N242), L265 (= L262), G267 (= G264), V268 (≠ I265), T269 (= T266), T312 (= T308)
- binding 2-[[4-chloranyl-2,6-bis(fluoranyl)phenyl]methylamino]-7-oxidanylidene-5-propyl-4H-pyrazolo[1,5-a]pyrimidine-3-carbonitrile: R142 (= R143), G153 (= G154), V154 (= V155), Y172 (= Y173), F173 (= F174), V181 (= V181), Q223 (= Q223), V237 (≠ L238), T239 (≠ G240), M240 (= M241), G311 (= G307), A313 (= A309), C317 (≠ T313)
2abjA Crystal structure of human branched chain amino acid transaminase in a complex with an inhibitor, c16h10n2o4f3scl, and pyridoxal 5' phosphate. (see paper)
41% identity, 90% coverage: 25:350/362 of query aligns to 25:356/366 of 2abjA
- active site: K202 (= K201)
- binding n'-(5-chlorobenzofuran-2-carbonyl)-2-(trifluoromethyl)benzenesulfonohydrazide: F29 (= F29), F75 (= F75), Y141 (= Y141), Y173 (= Y173), K202 (= K201), Q224 (= Q223), T240 (≠ G240), M241 (= M241), G312 (= G307), A314 (= A309), C315 (≠ A310)
- binding pyridoxal-5'-phosphate: R99 (= R99), R192 (= R191), K202 (= K201), Y207 (= Y206), E237 (= E237), T240 (≠ G240), M241 (= M241), N242 (= N242), L266 (= L262), G268 (= G264), V269 (≠ I265), T270 (= T266), T313 (= T308)
7nxnA Crystal structure of human cytosolic branched-chain aminotransferase (bcat1) in complex with plp and small molecule inhibitor compound 21(5-f) (see paper)
41% identity, 90% coverage: 25:350/362 of query aligns to 24:352/362 of 7nxnA
- binding pyridoxal-5'-phosphate: R98 (= R99), R188 (= R191), K198 (= K201), Y203 (= Y206), E233 (= E237), T236 (≠ G240), M237 (= M241), N238 (= N242), L262 (= L262), G264 (= G264), V265 (≠ I265), T266 (= T266), T309 (= T308)
- binding 4-[6-[bis(fluoranyl)-phenyl-methyl]-2,4-bis(oxidanylidene)-1~{H}-pyrimidin-3-yl]-5-fluoranyl-2-(2-methylphenoxy)benzenecarbonitrile: F28 (= F29), Y69 (= Y70), F74 (= F75), G153 (= G154), V154 (= V155), Y172 (= Y173), Q210 (= Q213), Q219 (≠ D222), Q220 (= Q223), T236 (≠ G240)
7ntrA Crystal structure of human cytosolic branched-chain aminotransferase (bcat1) in complex with plp and substrate mimic 3-phenylpropionate (see paper)
41% identity, 90% coverage: 25:350/362 of query aligns to 24:352/362 of 7ntrA
- binding hydrocinnamic acid: F28 (= F29), Y69 (= Y70), V154 (= V155), T236 (≠ G240), G308 (= G307), T309 (= T308), A310 (= A309)
- binding pyridoxal-5'-phosphate: R98 (= R99), R188 (= R191), K198 (= K201), Y203 (= Y206), E233 (= E237), T236 (≠ G240), M237 (= M241), L262 (= L262), G264 (= G264), V265 (≠ I265), T266 (= T266), G308 (= G307), T309 (= T308)
7nxoA Crystal structure of human cytosolic branched-chain aminotransferase (bcat1) in complex with plp and small molecule inhibitor compound 24(5-f) (see paper)
41% identity, 90% coverage: 25:350/362 of query aligns to 23:351/361 of 7nxoA
- binding pyridoxal-5'-phosphate: R97 (= R99), K197 (= K201), Y202 (= Y206), E232 (= E237), T235 (≠ G240), M236 (= M241), N237 (= N242), L261 (= L262), G263 (= G264), V264 (≠ I265), T265 (= T266), T308 (= T308)
- binding 4-[2,4-bis(oxidanylidene)-6-(phenylsulfonyl)-1H-pyrimidin-3-yl]-5-fluoranyl-2-(2-methylphenoxy)benzenecarbonitrile: F27 (= F29), Y68 (= Y70), F73 (= F75), G152 (= G154), V153 (= V155), Y171 (= Y173), F172 (= F174), Q209 (= Q213), Q218 (≠ D222), Q219 (= Q223), T235 (≠ G240)
2coiA Crystal structure of oxidized human cytosolic branched-chain aminotransferase complexed with gabapentin (see paper)
41% identity, 90% coverage: 26:350/362 of query aligns to 24:349/358 of 2coiA
- active site: K195 (= K201)
- binding [1-(aminomethyl)cyclohexyl]acetic acid: Y68 (= Y70), R141 (= R143), V153 (= V155), T233 (≠ G240), G305 (= G307), T306 (= T308), A307 (= A309)
- binding pyridoxal-5'-phosphate: R97 (= R99), R185 (= R191), K195 (= K201), Y200 (= Y206), E230 (= E237), T233 (≠ G240), L259 (= L262), G261 (= G264), V262 (≠ I265), T263 (= T266), T306 (= T308)
2cogA Crystal structure of oxidized human cytosolic branched-chain aminotransferase complexed with 4-methylvalerate (see paper)
41% identity, 90% coverage: 26:350/362 of query aligns to 24:349/358 of 2cogA
- active site: K195 (= K201)
- binding 4-methyl valeric acid: Y171 (= Y173), T233 (≠ G240), T306 (= T308), A307 (= A309)
- binding pyridoxal-5'-phosphate: R97 (= R99), K195 (= K201), Y200 (= Y206), E230 (= E237), T233 (≠ G240), L259 (= L262), G261 (= G264), V262 (≠ I265), T263 (= T266), T306 (= T308)
Query Sequence
>Ga0059261_3811 FitnessBrowser__Korea:Ga0059261_3811
VSSAMFEFEANPNPVPASERAALLENPGFGKLFTDHMAMVRWSDTKGWHDAKVVARGPLS
LDPATAVLHYAQEIFEGLKAYRTGDEGTALFRPLENARRFRESAQRMAMPELPDDLFLGS
IEALVKADREWIPQIEGGSLYLRPFMFASEVFLGVKPASEYLYLVIASPAGAYFKGGAPA
VTIWVSDHYTRAAPGGTGAAKCGGNYASSLVAQAEAIREGCDQVVFLDAVERRWVEELGG
MNLFFVFDDGSMVTPPLGGTILPGITRESILTLAREQGITVREEPYAIDQWKADAGSGKL
VETFACGTAAVVTPVGKVKSRDGEFTIGSGGPGQVTEALKARLTAIQRGQAPDIHGWVHR
FG
Or try a new SitesBLAST search
SitesBLAST's Database
SitesBLAST's database includes
(1) SwissProt
entries with experimentally-supported functional features;
and (2) protein structures with bound ligands, from the
BioLip database.
by Morgan Price,
Arkin group
Lawrence Berkeley National Laboratory